Loading...

AIMD AINOS INC Investments/Divestments 8-K Filing

NS N

MD

AINOS INC

(AIMD)

2024 8-K

Show Summary

Summary

Earnings Releases

Convertible Note Amendment

Contract Agreement

Convertible Note Amendment

Financial Results

Cooperation Agreement

Collaboration Agreement

Product Agreement Update

Annual Meeting Results

Patent License Agreement

Financial Results Q2 2024

Delisting Notice

Agreement with TCNT

Bylaws Amendment and Clinic...

Financial Results Announcement

Investment Agreement

Appointment of CFO

Resignation of CFO

Financial Results Announcement

FDA Submission for Phase 2 ...

Entry Into a Material Defin...

Product Development Agreement

Compliance Regained

Reverse Stock Split and Pre...

Reverse Stock Split

Equity Stock Awards

Results of Operations and F...

Securities Purchase Agreeme...

Promissory Note Extensions

Results of Operations and F...

Co-Development Agreement

Management Change

Change of Auditor

Convertible Note Sale

Delisting Notice

External Links:

Ainos, Inc. amended its bylaws to change quorum requirements and announced progress in clinical trials.

AI Assistant

AINOS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.